Unknown

Dataset Information

0

Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation.


ABSTRACT: We report how rotational variations in transmembrane (TM) helix interactions participate in the activity states of the thrombopoietin receptor (TpoR), a type 1 cytokine receptor that controls the production of blood platelets. We also explore the mechanism of small-molecule agonists that do not mimic the natural ligand. We show, by a combination of cysteine cross-linking, alanine-scanning mutagenesis, and computational simulations, that the TpoR TM dimerizes strongly and can adopt 3 different stable, rotationally related conformations, which may correspond to specific states of the full-length receptor (active, inactive, and partially active). Thus, our data suggest that signaling and inactive states of the receptor are related by receptor subunit rotations, rather than a simple monomer-dimer transition. Moreover, results from experiments with and without agonists in vitro and in cells allow us to propose a novel allosteric mechanism of action for a class of small molecules, in which they activate TpoR by binding to the TM region and by exploiting the rotational states of the dimeric receptor. Overall, our results support the emerging view of the participation of mutual rotations of the TM domains in cytokine receptor activation.

SUBMITTER: Matthews EE 

PROVIDER: S-EPMC3114528 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation.

Matthews Erin E EE   Thévenin Damien D   Rogers Julia M JM   Gotow Lisa L   Lira Paul D PD   Reiter Lawrence A LA   Brissette William H WH   Engelman Donald M DM  

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110314 7


We report how rotational variations in transmembrane (TM) helix interactions participate in the activity states of the thrombopoietin receptor (TpoR), a type 1 cytokine receptor that controls the production of blood platelets. We also explore the mechanism of small-molecule agonists that do not mimic the natural ligand. We show, by a combination of cysteine cross-linking, alanine-scanning mutagenesis, and computational simulations, that the TpoR TM dimerizes strongly and can adopt 3 different st  ...[more]

Similar Datasets

| S-EPMC3574938 | biostudies-literature
| S-EPMC9177810 | biostudies-literature
| S-EPMC4824752 | biostudies-literature
| S-EPMC4020789 | biostudies-literature
| S-EPMC10076285 | biostudies-literature
| S-EPMC6588349 | biostudies-literature
| S-EPMC6838755 | biostudies-literature
| S-EPMC4210147 | biostudies-literature
| S-EPMC3328699 | biostudies-literature
| S-EPMC4777841 | biostudies-literature